iRhythm Technologies (IRTC) Financials: History & Chart

iRhythm Technologies, Inc.(IRTC)

Medical - Devices · San Francisco, CA

$107.61-1.48 (-1.36%)

Delayed quote: Oct 6, 2026, 11:35 AM EDT

About iRhythm Technologies, Inc.

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.

San Francisco, CA

2,400 employees

www.irhythmtech.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Quentin S. Blackford

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	825.34M	224.17M	199.39M	208.89M	192.88M	186.69M	158.68M	164.32M	147.54M
Cost of Goods Sold	235.60M	60.97M	58.04M	60.84M	55.76M	53.83M	49.46M	49.26M	46.06M
Gross Profit	589.74M	163.21M	141.35M	148.06M	137.12M	132.86M	109.22M	115.07M	101.48M
Gross Profit Margin	71.5%	72.8%	70.9%	70.9%	71.1%	71.2%	68.8%	70.0%	68.8%
Total Operating Expenses	599.37M	165.75M	153.21M	139.29M	141.12M	147.39M	141.48M	119.15M	151.78M
Research & Development	83.28M	19.84M	21.36M	21.05M	21.03M	21.01M	21.52M	19.38M	47.76M
Selling, General & Administrative	505.87M	131.66M	135.88M	118.24M	120.09M	126.38M	119.96M	99.77M	103.38M
Operating Income (EBIT)	-9.63M	-2.54M	-11.85M	8.77M	-4.00M	-14.53M	-32.26M	-4.08M	-50.30M
Operating Margin	-1.2%	-1.1%	-5.9%	4.2%	-2.1%	-7.8%	-20.3%	-2.5%	-34.1%
Income Before Tax (EBT)	-12.98M	-381K	-13.43M	6.03M	-5.19M	-14.40M	-30.04M	-1.18M	-45.99M
Interest Income	20.94M	4.78M	4.88M	5.34M	5.94M	5.32M	4.92M	5.74M	6.46M
Interest Expense	13.19M	3.29M	3.29M	3.32M	3.28M	3.28M	3.27M	3.32M	3.33M
Other Income/Expense	-3.35M	2.16M	-1.58M	-2.74M	-1.19M	130K	2.22M	2.90M	4.31M
Net Income	-13.95M	-381K	-13.93M	5.58M	-5.21M	-14.22M	-30.70M	-1.33M	-46.18M
Income Tax Expense	971K	0.00	500K	447K	24K	-183K	665K	151K	188K
Net Profit Margin	-1.7%	-0.2%	-7.0%	2.7%	-2.7%	-7.6%	-19.3%	-0.8%	-31.3%
EBITDA	13.98M	1.18M	-5.31M	15.49M	2.62M	-8.00M	-25.66M	2.52M	-43.91M
EBITDA Margin	1.7%	0.5%	-2.7%	7.4%	1.4%	-4.3%	-16.2%	1.5%	-29.8%
Depreciation & Amortization	23.61M	3.72M	6.54M	6.73M	6.62M	6.53M	6.60M	6.60M	6.40M
EPS Basic	-0.43	-0.01	-0.43	0.17	-0.16	-0.44	-0.97	-0.04	-1.48
EPS Diluted	-0.43	-0.01	-0.43	0.17	-0.16	-0.44	-0.97	-0.04	-1.48
Weighted Average Basic Shares	32.90M	32.90M	32.51M	32.26M	32.17M	31.99M	31.59M	31.34M	31.26M
Weighted Average Diluted Shares	32.90M	32.90M	32.51M	33.33M	32.17M	31.99M	31.59M	31.34M	31.26M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	747.14M	591.84M	492.68M	410.92M	322.82M	265.17M	214.55M	147.28M
Cost of Goods Sold	219.89M	184.31M	160.88M	129.29M	109.26M	70.28M	52.48M	38.80M
Gross Profit	527.25M	407.53M	331.81M	281.63M	213.57M	194.89M	162.07M	108.48M
Gross Profit Margin	70.6%	68.9%	67.3%	68.5%	66.2%	73.5%	75.5%	73.7%
Total Operating Expenses	564.06M	523.04M	456.97M	395.42M	313.51M	238.56M	216.82M	154.17M
Research & Development	84.61M	103.83M	60.24M	46.61M	38.67M	41.33M	37.30M	20.86M
Selling, General & Administrative	479.45M	418.56M	385.64M	322.20M	274.84M	197.23M	179.52M	133.31M
Operating Income (EBIT)	-36.81M	-115.50M	-125.16M	-113.78M	-99.94M	-43.67M	-54.76M	-45.69M
Operating Margin	-4.9%	-19.5%	-25.4%	-27.7%	-31.0%	-16.5%	-25.5%	-31.0%
Income Before Tax (EBT)	-43.60M	-112.72M	-122.66M	-115.89M	-100.99M	-43.60M	-54.50M	-50.33M
Interest Income	21.52M	21.94M	6.16M	2.35M	118K	N/A	N/A	N/A
Interest Expense	13.15M	12.82M	3.65M	4.14M	1.17M	1.52M	1.64M	3.12M
Other Income/Expense	-6.79M	2.78M	2.50M	-2.10M	-1.05M	72K	252K	-4.64M
Net Income	-44.55M	-113.29M	-123.41M	-116.16M	-101.36M	-43.83M	-54.57M	-50.38M
Income Tax Expense	953K	565K	750K	269K	367K	229K	65K	44K
Net Profit Margin	-6.0%	-19.1%	-25.0%	-28.3%	-31.4%	-16.5%	-25.4%	-34.2%
EBITDA	-10.33M	-89.73M	-103.02M	-94.17M	-83.35M	-30.74M	-51.31M	-43.42M
EBITDA Margin	-1.4%	-15.2%	-20.9%	-22.9%	-25.8%	-11.6%	-23.9%	-29.5%
Depreciation & Amortization	26.48M	25.78M	22.14M	19.61M	16.59M	12.93M	3.44M	2.27M
EPS Basic	-1.39	-3.63	-4.04	-3.88	-3.46	-1.58	-2.16	-2.02
EPS Diluted	-1.39	-3.63	-4.04	-3.88	-3.46	-1.58	-2.16	-2.02
Weighted Average Basic Shares	32.00M	31.20M	30.53M	29.92M	29.33M	27.75M	25.27M	23.89M
Weighted Average Diluted Shares	32.00M	31.20M	30.53M	29.92M	29.33M	27.75M	25.27M	23.89M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.